It was found that MeCP2 via up-regulating may contribute to hepatic fibrosis and then observed that HZ-6 h administered in a dose-dependent manner reduced the expression of MeCP2, α-SMA expression, and collagen I in HSC-T6 cells (He et al. 2016). The gene discussed is ACTA1; the disease is Hepatic fibrosis.